The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific

被引:84
|
作者
Niyuhire, Floride [1 ]
Varvel, Stephen A. [1 ]
Thorpe, Andrew J. [1 ]
Stokes, Rene J. [1 ]
Wiley, Jenny L. [1 ]
Lichtman, Aron H. [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
freezing; working memory; passive avoidance; fear conditioning; extinction; cannabinoid; operant conditioning task; marijuana; SR141716 (rimonabant); endocannabinoid;
D O I
10.1007/s00213-006-0650-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Disruption of CB1 receptor signaling through the use of CB1 (-/-) mice or the CB1 receptor antagonist rimonabant (SR141716) has been demonstrated to impair extinction of learned responses in conditioned fear and Morris water maze tasks. In contrast, CB1 (-/-) mice exhibited normal extinction rates in an appetitively motivated operant conditioning task. Objectives The purpose of this study was to test whether rimonabant would differentially disrupt extinction learning between fear-motivated and food-motivated tasks. Materials and methods Separate groups of C57BL/6J mice were trained in two aversively motivated tasks, conditioned freezing and passive avoidance, and an appetitively motivated operant conditioning task at a fixed ratio (FR-5) schedule of food reinforcement. After acquisition, the respective reinforcers in each task were withheld, and an intraperitoneal injection of vehicle or rimonabant was given 30 min before each extinction session. Results Rimonabant (3 mg/kg) treatment significantly disrupted extinction in both the conditioned freezing and passive avoidance tasks but failed to affect extinction rates in the operant conditioning task, whether using daily or weekly extinction sessions. Interestingly, rimonabant (3 mg/kg) prevented the significant increases in lever pressing (i.e., extinction burst) that occurred during the first extinction session of the operant conditioning task. Conclusions These results support the hypothesis that the CB1 receptor plays a vital role in the extinction of aversive memories but is not essential for extinction of learned responses in appetitively motivated tasks.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [21] Effect of Cannabinoid CB1 Receptor Antagonist SR141714A and CB1 Receptor Knockout on Cue-Induced Reinstatement of Ensure® and Corn-Oil Seeking in Mice
    Sara Jane Ward
    Ellen A Walker
    Linda A Dykstra
    Neuropsychopharmacology, 2007, 32 : 2592 - 2600
  • [22] The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse
    Ward, Sara Jane
    Rosenberg, Marisa
    Dykstra, Linda A.
    Walker, Ellen A.
    DRUG AND ALCOHOL DEPENDENCE, 2009, 105 (03) : 248 - 255
  • [23] CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action
    Joel E. Schlosburg
    Scott T. O’Neal
    Daniel H. Conrad
    Aron H. Lichtman
    Psychopharmacology, 2011, 216 : 323 - 331
  • [24] CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action
    Schlosburg, Joel E.
    O'Neal, Scott T.
    Conrad, Daniel H.
    Lichtman, Aron H.
    PSYCHOPHARMACOLOGY, 2011, 216 (03) : 323 - 331
  • [25] The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin
    Tucci, SA
    Rogers, EK
    Korbonits, M
    Kirkham, TC
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 520 - 523
  • [26] Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia
    Haller, J
    Szirmai, M
    Varga, B
    Ledent, C
    Freund, TF
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 415 - 422
  • [27] NOVEL ANTAGONIST IMPLICATES THE CB1 CANNABINOID RECEPTOR IN THE HYPOTENSIVE ACTION OF ANANDAMIDE
    VARGA, K
    LAKE, K
    MARTIN, BR
    KUNOS, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (03) : 279 - 283
  • [28] Characterization of a novel and selective CB1 antagonist as a radioligand for receptor occupancy studies
    Yang, Yifan
    Miller, Keith J.
    Zhu, Yeheng
    Hong, Yang
    Tian, Yuan
    Murugesan, Natesan
    Gu, Zhengxiang
    O'Tanyi, Eva
    Keim, William J.
    Rohrbach, Kenneth W.
    Johnghar, Susan
    Behnia, Kamelia
    Pelleymounter, Mary Ann
    Carlson, Kenneth E.
    Ewing, William R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6856 - 6860
  • [29] The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats
    Serrano, Antonia
    del Arco, Ignacio
    Javier Pavon, Francisco
    Macias, Manuel
    Perez-Valero, Vidal
    Rodriguez de Fonseca, Fernando
    NEUROPHARMACOLOGY, 2008, 54 (01) : 226 - 234
  • [30] Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine
    Khaleghzadeh-Ahangar, Hossein
    Haghparast, Abbas
    PHYSIOLOGY & BEHAVIOR, 2015, 149 : 212 - 219